Cargando…

New genomic techniques and their European Union reform. Potential policy changes and their implications

The article discusses amendment options (no significant change, lowering of administrative burdens or exemption of certain products from the legislation) for the European Union (EU) authorization procedures of New Genomic Techniques’ (NGT) products and their consequences for the sector and research...

Descripción completa

Detalles Bibliográficos
Autor principal: Zimny, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562193/
https://www.ncbi.nlm.nih.gov/pubmed/36246372
http://dx.doi.org/10.3389/fbioe.2022.1019081
_version_ 1784808115360759808
author Zimny, Tomasz
author_facet Zimny, Tomasz
author_sort Zimny, Tomasz
collection PubMed
description The article discusses amendment options (no significant change, lowering of administrative burdens or exemption of certain products from the legislation) for the European Union (EU) authorization procedures of New Genomic Techniques’ (NGT) products and their consequences for the sector and research institutions, particularly in the context of internal functioning, placing products on the market and international trade. A reform of the EU regulatory system requires a change in the procedures for the authorization of NGT products, otherwise EU researchers and investors may still be at a competitive disadvantage (as compared to Argentina, Brazil, Canada, United States or the United Kingdom) due to the inefficiency of the current system and the committee procedure for authorization. New legislation, currently being adopted in the United Kingdom is also presented for comparison.
format Online
Article
Text
id pubmed-9562193
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95621932022-10-15 New genomic techniques and their European Union reform. Potential policy changes and their implications Zimny, Tomasz Front Bioeng Biotechnol Bioengineering and Biotechnology The article discusses amendment options (no significant change, lowering of administrative burdens or exemption of certain products from the legislation) for the European Union (EU) authorization procedures of New Genomic Techniques’ (NGT) products and their consequences for the sector and research institutions, particularly in the context of internal functioning, placing products on the market and international trade. A reform of the EU regulatory system requires a change in the procedures for the authorization of NGT products, otherwise EU researchers and investors may still be at a competitive disadvantage (as compared to Argentina, Brazil, Canada, United States or the United Kingdom) due to the inefficiency of the current system and the committee procedure for authorization. New legislation, currently being adopted in the United Kingdom is also presented for comparison. Frontiers Media S.A. 2022-09-30 /pmc/articles/PMC9562193/ /pubmed/36246372 http://dx.doi.org/10.3389/fbioe.2022.1019081 Text en Copyright © 2022 Zimny. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Zimny, Tomasz
New genomic techniques and their European Union reform. Potential policy changes and their implications
title New genomic techniques and their European Union reform. Potential policy changes and their implications
title_full New genomic techniques and their European Union reform. Potential policy changes and their implications
title_fullStr New genomic techniques and their European Union reform. Potential policy changes and their implications
title_full_unstemmed New genomic techniques and their European Union reform. Potential policy changes and their implications
title_short New genomic techniques and their European Union reform. Potential policy changes and their implications
title_sort new genomic techniques and their european union reform. potential policy changes and their implications
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562193/
https://www.ncbi.nlm.nih.gov/pubmed/36246372
http://dx.doi.org/10.3389/fbioe.2022.1019081
work_keys_str_mv AT zimnytomasz newgenomictechniquesandtheireuropeanunionreformpotentialpolicychangesandtheirimplications